Lonza appoints new Chief Executive
European Pharmaceutical Review
APRIL 2, 2024
Baehny has held his Chief Executive Officer ad interim role since October 2023 and will support Wienand through the transition period. The post Lonza appoints new Chief Executive appeared first on European Pharmaceutical Review. Wienand will join the contract development and manufacturing organisation (CDMO) in the summer of 2024.
Let's personalize your content